MedPath

Doburis

Brand Name: Doburis

Generic Name: Dobutamine (as hydrochloride)

Expiring Soon
Registration Number

DRP-10264

Dosage Form

Solution for Intravenous Infusion

Issuance Date

September 13, 2021

Expiry Date

October 31, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/mL
PackagingIn a box of 1-Type I Amber Ampoule x 5 mL Box of 5's

Classification

C
Classification
Prescription Drug (Rx)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dobutamine (as hydrochloride)Active
Monograph: dobutamine (as hydrochloride)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform